Related Experiment Video
Updated: Sep 13, 2025

Deacetylation Assays to Unravel the Interplay between Sirtuins SIRT2 and Specific Protein-substrates
Published on: February 27, 2016
Sirtuins in Central Nervous System Tumors-Molecular Mechanisms and Therapeutic Targeting
Agnieszka Nowacka1, Martyna Śniegocka2, Maciej Śniegocki1
1Department of Neurosurgery, Collegium Medicum in Bydgoszcz, Nicolas Copernicus University in Toruń, ul. Curie Skłodowskiej 9, 85-094 Bydgoszcz, Poland.
Abstract:
Sirtuins (SIRTs), a family of NAD+-dependent enzymes, play crucial roles in epigenetic regulation, metabolism, DNA repair, and stress response, making them relevant to glioma biology. This review systematically summarizes the molecular mechanisms and context-specific functions of SIRT1-SIRT7 in central nervous system tumors, with particular focus on gliomas. SIRT1, SIRT3, SIRT5, and SIRT7 are often overexpressed and promote glioma cell proliferation, stemness, therapy resistance, and metabolic adaptation. Conversely, SIRT2, SIRT4, and SIRT6 generally exhibit tumor-suppressive functions by inducing apoptosis, inhibiting invasion, and counteracting oncogenic signaling. Preclinical studies have identified several sirtuin modulators-both inhibitors and activators-that alter tumor growth, sensitize cells to temozolomide, and regulate pathways such as JAK2/STAT3, NF-κB, and mitochondrial metabolism. Emerging evidence positions sirtuins as promising targets for glioma therapy. Future studies should evaluate sirtuin modulators in clinical trials and explore their potential for patient stratification and combined treatment strategies.
Insights
Sirtuins (SIRTs) impact glioma by promoting or suppressing tumors. Modulators targeting these enzymes show promise for novel glioma therapies and patient stratification.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Sirtuins (SIRTs) are NAD+-dependent enzymes involved in critical cellular processes.
- Their roles in epigenetic regulation, metabolism, DNA repair, and stress response are relevant to glioma biology.
Purpose of the Study:
- To systematically review the molecular mechanisms and context-specific functions of SIRT1-SIRT7 in central nervous system tumors, focusing on gliomas.
- To explore the therapeutic potential of sirtuin modulators in glioma treatment.
Main Methods:
- Systematic review of literature on sirtuins in central nervous system tumors.
- Analysis of preclinical studies on sirtuin modulators and their effects on glioma cells.
Main Results:
- SIRT1, SIRT3, SIRT5, and SIRT7 are frequently overexpressed, promoting glioma progression.
- SIRT2, SIRT4, and SIRT6 generally act as tumor suppressors.
- Sirtuin modulators impact tumor growth, chemoresistance, and key signaling pathways (e.g., JAK2/STAT3, NF-κB).
Conclusions:
- Sirtuins represent promising therapeutic targets for glioma.
- Further clinical evaluation of sirtuin modulators is warranted for combined strategies and patient stratification.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
lncRNA - Long Non-coding RNAs
Drugs that Stabilize Microtubules
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...

